News
We would be genuinely pleased to discuss your project. So, if you have a particular need, please take a moment to fill in our contact form
Texcell & GTP Bioways – A business partnership to provide extended services to biopharmaceutical companies
Polygon Therapeutics & GTP Bioways – Cell line development for a novel antibody
GTP Bioways will open two new biopharmaceutical production units by mid-2023
LinKinVax & GTP Bioways – Development and production of a vaccine against SARS-CoV-2
Vakona & GTP Bioways – New acne medicine takes one step closer to market launch
Nasal Vaccine to Fight Covid-19 (in French)
L’offensive des CDMO – Passerelles IMT
GTP Nano & CEA validate an innovative manufacturing model for nanodrugs
Biomunex alongside Institut Curie and GTP Bioways awarded by the ‘Grand Défi Biomédicament’
![[In the press] Interview in Pharmaceutiques](https://www.olon-france.com/wp-content/uploads/2021/09/Alain_Sainsot_Pharmanetwork_V2-993x675.jpg)
[In the press] Interview in Pharmaceutiques
GTP Bioways invests €12M in two GMP biopharmaceutical production units
We offer customized solutions, contact us to discuss your project
GTP Bioways started providing custom recombinant protein production services in 2000 to accelerate biopharmaceutical development and overcome a wide range of challenges.
